A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION)
Clinical trial NCT01610791 · COMPLETED
Trial details
- NCT number
- NCT01610791
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-08-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.